As of late August 2026, the strong market-implied odds against a new pandemic reflect the absence of confirmed novel pathogens with sustained human-to-human transmission capable of triggering WHO pandemic declarations, according to ongoing CDC and WHO surveillance. Official case data show only localized outbreaks of known respiratory viruses like influenza and RSV, with no evidence of exponential growth or new zoonotic spillovers meeting epidemic thresholds. Historical patterns indicate most emerging threats remain contained through rapid genomic monitoring and public health responses, supporting trader consensus on low likelihood through year-end. Still, realistic shifts could arise from undetected mutations in avian influenza strains or sudden international case surges before final reporting deadlines.